ClinicalTrials.Veeva

Menu

Agreement and Accuracy of Different Devices for Biometry Measurements in Patients With Cataract (Comparison)

Medical University of Vienna logo

Medical University of Vienna

Status

Unknown

Conditions

Cataract
Surgery
Cornea

Treatments

Diagnostic Test: Keratometry
Diagnostic Test: Biometry

Study type

Interventional

Funder types

Other

Identifiers

NCT04323358
1845/2019

Details and patient eligibility

About

The rationale of this study is to compare repeatability, reproducibility and agreement of three different AS-OCT devices and Pentacam.

The investigational devices are approved biometry and keratometry devices to perform biometric/keratometric measurements preoperatively before cataract surgery. The measurements are used to calculate the needed IOL power.

Measurements with all four devices will be performed 3 times consecutively by two trained observer. The order of the observer, the order of devices as well as the eye (left/right) is randomized.

Examinations will be implemented in accordance with the approved investigational plan on subjects and includes: repeated biometry/keratometry with four different devices

Full description

The rationale of this study is to compare repeatability, reproducibility and agreement of both, AS-OCT(s) and Pentacam. In our department three different AS-OCT devices and a HR Scheimpflug imaging device are currently in use for clinical routine to measure the cornea. Among refractive and anterior segment surgeons, there is no preferred and accepted method for accurate measurements of the corneal curvature. The four diagnostic tools are based on different technical and physical imaging principles and to date only limited information on their comparability exist. One advantage of ASOCT represents faster imaging speed when compared to Scheimpflug imaging. Thus, imaging misalignment, segmentation errors and defocus aberration can most likely be avoided by AS-OCT. Chen et al demonstrated that HR Scheimpflug imaging measurements of CCT were systematically higher than the measurements provided by FD AS-OCT. Further, repeatability, reproducibility and agreement of AS-OCT and Scheimpflug imaging device will be assessed during follow-up.

Enrollment

50 estimated patients

Sex

All

Ages

40 to 95 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age-related cataract
  • Age 40 and older (females of childbearing age will be interviewed if pregnancy is possible)

Exclusion criteria

  • Contact lens wear within 5 days
  • Pathologic changes of the cornea, eye lid or conjunctiva on slit- lamp examination
  • History of corneal ocular surgery
  • Microphthalmus
  • Recurrent intraocular inflammation of unknown etiology
  • Blind fellow eye
  • Uncontrolled systemic or ocular disease

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Quadruple Blind

50 participants in 4 patient groups

IOL Master® 700
Active Comparator group
Description:
Biometry will be performed three times consecutively.
Treatment:
Diagnostic Test: Biometry
Diagnostic Test: Keratometry
Pentacam®
Active Comparator group
Description:
Keratometry will be performed three times consecutively.
Treatment:
Diagnostic Test: Keratometry
Casia II®
Active Comparator group
Description:
Keratometry will be performed three times consecutively.
Treatment:
Diagnostic Test: Keratometry
Spectralis Anterion®
Active Comparator group
Description:
Biometry will be performed three times consecutively.
Treatment:
Diagnostic Test: Biometry
Diagnostic Test: Keratometry

Trial contacts and locations

1

Loading...

Central trial contact

Veronika Röggla, MD; Christina Leydolt, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems